Cargando…
Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications
Protein-coding genes represent only a small fraction of the human genome. In the past, the majority of the genomic sequence has been considered transcriptionally silent, but recent large-scale studies have uncovered an array of functionally significant elements, including non-protein-coding transcri...
Autores principales: | Leti, Fatjon, DiStefano, Johanna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575670/ https://www.ncbi.nlm.nih.gov/pubmed/28829354 http://dx.doi.org/10.3390/genes8080207 |
Ejemplares similares
-
Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma
por: DiStefano, Johanna K.
Publicado: (2017) -
MALAT1 as a Diagnostic and Therapeutic Target in Diabetes-Related Complications: A Promising Long-Noncoding RNA
por: Abdulle, Leila Elmi, et al.
Publicado: (2019) -
Roles of long noncoding RNAs and small extracellular vesicle‐long noncoding RNAs in type 2 diabetes
por: Chang, Wenguang, et al.
Publicado: (2022) -
Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets
por: Min, Li, et al.
Publicado: (2017) -
Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets
por: Fatima, Roshan, et al.
Publicado: (2015)